Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations

Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations

Dec 12, 2019
|
Andrew P. Han
Premium

This story has been updated to include information about Twist Bioscience's filing for a stock offering worth up to $200 million. 

NEW YORK – Twist Bioscience is looking to deliver new products based off its synthetic DNA manufacturing platform as well as new biopharma partnerships over the rest of fiscal year 2020.

The San Francisco-based firm will be expanding its product line in several directions, CEO and Cofounder Emily Leproust said on a conference call on Wednesday following the release of the firm's fiscal fourth quarter and full-year 2019 financial results.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Director of Both, For Now

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

From CRISPR Lab to COVID-19 Lab

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

Behind on Testing

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Nature Papers Present New CRISPR Screening Approach, Discuss CRISPR in Crop Breeding, More

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Sequencing

  1. The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications

    Premium

  2. Bionano Prices $18M Stock, Warrant Offering

  3. Stanford Team Debuts New Liquid Biopsy Lung Cancer Screening Method

    Premium

  4. Idiopathic Pulmonary Arterial Hypertension Sequencing Study Identifies New Susceptibility Gene

  5. SARS-CoV-2-Related Coronaviruses Found in Pangolins

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.